Page last updated: 2024-08-24

coomassie brilliant blue and oxidopamine

coomassie brilliant blue has been researched along with oxidopamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrade, GM; Canas, PM; Carmo, MR; Cunha, RA; Menezes, AP; Nunes, AC; Palmeira, CM; Pliássova, A; Rolo, AP	1

Other Studies

1 other study(ies) available for coomassie brilliant blue and oxidopamine

Article	Year
The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis. Neuropharmacology, 2014, Volume: 81 Topics: Animals; Avoidance Learning; Brain; Cell Line, Tumor; Disease Models, Animal; Exploratory Behavior; Functional Laterality; Gliosis; Male; Maze Learning; Memory Disorders; Motor Activity; Neurotoxicity Syndromes; Oxidopamine; Parkinsonian Disorders; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; Reaction Time; Rosaniline Dyes	2014

Article

Year

The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis.

Neuropharmacology, 2014, Volume: 81

Topics: Animals; Avoidance Learning; Brain; Cell Line, Tumor; Disease Models, Animal; Exploratory Behavior; Functional Laterality; Gliosis; Male; Maze Learning; Memory Disorders; Motor Activity; Neurotoxicity Syndromes; Oxidopamine; Parkinsonian Disorders; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; Reaction Time; Rosaniline Dyes

2014